PREDICTING RESPONSE TO CHEMOTHERAPY IN HIGH GRADE GLIOMAS USING EX VIVO 3D CELL CULTURE FUNCTIONAL PRECISION ONCOLOGY PLATFORM - A MULTI-INSTITUTIONAL EXPERIENCE

被引：0
|
作者：
Mrugala, Maciej [1 ]
Hrachova, Maya [2 ]
Sherman, Wendy [3 ]
Ensign, Shannon Fortin [4 ]
Blomquist, Mylan [5 ]
Porter, Alyx [1 ]
Thompson, Tracy [5 ]
Greene, Denia [5 ]
Anastasiadis, Panos
Vasmatzis, George [6 ]
Lin, Wan-Hsin
Dunn, Ian [2 ]
Quinones-Hinojosa, Alfredo [3 ]
Zimmerman, Richard
Swanson, Kristin [5 ]
Bendok, Bernard [7 ]
机构：
[1] Mayo Clin Arizona, Phoenix, AZ USA
[2] Univ Oklahoma, Oklahoma City, OK USA
[3] Mayo Clin Florida, Jacksonville, FL USA
[4] Mayo Clin Arizona, Scottsdale, AZ USA
[5] Mayo Clin, Phoenix, AZ USA
[6] Mayo Clin Rochester, Rochester, MN USA
[7] Mayo Clin Arizona, Dept Neurosurg, Phoenix, AZ USA
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
INNV-20
引用
收藏
页数：2
相关论文
共 20 条
  • [1] PREDICTING RESPONSE TO CHEMOTHERAPY IN RECURRENT HIGH GRADE GLIOMAS USING EX VIVO 3D CELL CULTURE FUNCTIONAL PRECISION ONCOLOGY PLATFORM
    Mrugala, M. M.
    Zimmerman, R.
    Greene, D.
    Fortin-Ensign, S.
    Blomquist, M.
    Swanson, K.
    Bendok, B.
    NEURO-ONCOLOGY, 2023, 25
  • [2] Prospective prediction of clinical drug response in highgrade gliomas using an ex vivo 3D cell culture assay
    Shuford, Stephen
    Lipinski, Lindsay
    Abad, Ajay
    Smith, Ashley M.
    Rayner, Melissa
    O'Donnell, Lauren
    Stuart, Jeremy
    Mechtler, Laszlo L.
    Fabiano, Andrew J.
    Edenfield, Jeff
    Kanos, Charles
    Gardner, Stephen
    Hodge, Philip
    Lynn, Michael
    Butowski, Nicholas A.
    Han, Seunggu J.
    Redjal, Navid
    Crosswell, Howland E.
    Vibat, Cecile Rose T.
    Holmes, Lillia
    Gevaert, Matthew
    Fenstermaker, Robert A.
    DesRochers, Teresa M.
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [3] 3D conformal radiation therapy (3DCRT) for high grade prostate cancer: A multi-institutional review
    Fiveash, JB
    Hanks, G
    Roach, M
    Wang, SB
    Vigneault, E
    McLaughlin, PW
    Sandler, HM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (02): : 335 - 342
  • [4] Measuring immunotherapy responses ex vivo using novel 3D culture platform: E-slice
    Gallup, Thomas D.
    Maldonado, Jose A.
    Margain, Corina
    Kim, Min P.
    Gallup, David F.
    Yun, Kyuson
    CANCER RESEARCH, 2023, 83 (07)
  • [5] Development of the drug efficacy testing in ex vivo 3D cultures (DETECT) platform and its application to functional precision medicine in ovarian cancer
    Akerlund, Emma
    Gudoityte, Greta
    Lamodiere, Elisabeth Moussaud
    Carlson, Joseph
    Wallin, Emelie
    Fernebro, Josefin
    Kallioniemi, Olli
    Ostling, Paivi
    Joneborg, Ulrika
    Seashore-Ludlow, Brinton
    CANCER RESEARCH, 2022, 82 (12)
  • [6] CLINICAL APPLICABILITY OF INDIVIDUALIZED DRUG RESPONSE PROFILING UTILIZING EX-VIVO TISSUE-DERIVED 3D CELL CULTURE ASSAYS IN HIGH-GRADE GLIOMA: A SINGLE INSTITUTION CASE SERIES USING 3D-PREDICT RESULTS
    Lipinski, Lindsay
    Abad, Ajay
    Mechtler, Laszlo
    Fabiano, Andrew
    Smith, Ashley
    DesRochers, Teresa
    Gevaert, Matthew
    Vibat, Cecile Rose
    Fenstermaker, Robert
    NEURO-ONCOLOGY, 2020, 22 : 119 - 120
  • [7] Novel patient avatar platform for oncology drug testing using 3D ex vivo models derived from fresh patient tumor tissues
    Beztsinna, Nataliia
    Grillet, Fanny
    Meesters, Niels
    van der Meer, Donny
    Daszkiewicz, Lidia
    Yan, Kuan
    Spanjaard, Emma
    Vader, Willemijn
    Price, Leo
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [8] High Throughput Screening of Cell Mechanical Response Using a Stretchable 3D Cellular Microarray Platform
    Sakthivel, Kabilan
    Kumar, Hitendra
    Mohamed, Mohamed G. A.
    Talebjedi, Bahram
    Shim, Justin
    Najjaran, Homayoun
    Hoorfar, Mina
    Kim, Keekyoung
    SMALL, 2020, 16 (30)
  • [9] An established ex vivo 3D culture platform using patient-derived xenograft (PDX) tumors replicate the anti-tumor efficacy observed in vivo
    Xu, Xiaoxi
    Zhang, Wenna
    Xie, Bingying
    Bao, Zheng Zheng
    Mei, Zhu
    Wery, Jean-Pierre
    Ning, Jinying
    CANCER RESEARCH, 2016, 76
  • [10] Chemotherapy testing of primary human ovarian cancers in an ex vivo 3D culture platform: A novel method of phenotypic profiling for clinical trial selection and personalized medicine
    Shuford, Stephen
    Widener, Rebecca
    Cheluvaraju, Chaitra
    Desrochers, Teresa
    Mattingly, Christina
    Puls, Larry
    Gevaert, Matt
    Orr, David
    Crosswell, Hal E.
    CANCER RESEARCH, 2014, 74 (19)
12